[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR3101542B1 - UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION - Google Patents

UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION Download PDF

Info

Publication number
FR3101542B1
FR3101542B1 FR1910995A FR1910995A FR3101542B1 FR 3101542 B1 FR3101542 B1 FR 3101542B1 FR 1910995 A FR1910995 A FR 1910995A FR 1910995 A FR1910995 A FR 1910995A FR 3101542 B1 FR3101542 B1 FR 3101542B1
Authority
FR
France
Prior art keywords
plant cells
alpinum
cosmetic treatment
leontodium
antiglycation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1910995A
Other languages
English (en)
Other versions
FR3101542A1 (fr
Inventor
Philippe Mondon
Nathalie Rouyer
Laure Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR1910995A priority Critical patent/FR3101542B1/fr
Priority to CN202080069753.1A priority patent/CN114502140A/zh
Priority to PCT/EP2020/077659 priority patent/WO2021064173A1/fr
Priority to EP20785974.5A priority patent/EP4037656A1/fr
Publication of FR3101542A1 publication Critical patent/FR3101542A1/fr
Application granted granted Critical
Publication of FR3101542B1 publication Critical patent/FR3101542B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Selon l’invention, il est proposé l’utilisation de cellules végétales indifférenciées ou dédifférenciées de Leontopodium alpinum obtenues par culture cellulaire in vitro, pour un traitement cosmétique non thérapeutique pour prévenir la glycation de macro-molécules de la peau, notamment les protéines, les acides nucléiques et/ou les lipides.
FR1910995A 2019-10-04 2019-10-04 UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION Active FR3101542B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1910995A FR3101542B1 (fr) 2019-10-04 2019-10-04 UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION
CN202080069753.1A CN114502140A (zh) 2019-10-04 2020-10-02 高山火绒草植物细胞用于抗糖化作用的抗衰老美容处理
PCT/EP2020/077659 WO2021064173A1 (fr) 2019-10-04 2020-10-02 Utilisation de cellules végétales de leontodium alpinum pour un traitement cutané anti-âge anti-glycation
EP20785974.5A EP4037656A1 (fr) 2019-10-04 2020-10-02 Utilisation de cellules végétales de leontodium alpinum pour un traitement cutané anti-âge anti-glycation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1910995A FR3101542B1 (fr) 2019-10-04 2019-10-04 UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION
FR1910995 2019-10-04

Publications (2)

Publication Number Publication Date
FR3101542A1 FR3101542A1 (fr) 2021-04-09
FR3101542B1 true FR3101542B1 (fr) 2022-10-28

Family

ID=69158061

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1910995A Active FR3101542B1 (fr) 2019-10-04 2019-10-04 UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION

Country Status (4)

Country Link
EP (1) EP4037656A1 (fr)
CN (1) CN114502140A (fr)
FR (1) FR3101542B1 (fr)
WO (1) WO2021064173A1 (fr)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802769B1 (fr) * 1999-12-23 2004-01-16 Oreal Extrait de vegetal du genre leontopodium et compositions le contenant
FR2821086B1 (fr) 2001-02-21 2003-12-12 Sederma Sa Procede de fabrication de proteines par fermentation de microorganismes de la famille thermus, melange de proteines ainsi obtenu et composition cosmetique les contenant
FR2836042B1 (fr) 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
FR2927801B1 (fr) 2008-02-22 2010-03-05 Sederma Sa Composition cosmetique hydratante comprenant une combinaison d'homarine et d'erythritol
EP2319914A1 (fr) 2009-11-09 2011-05-11 I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. Préparation et utilisation de cellules de méristèmes avec une teneur élevée en dérivés d'acide caféique
FR2980362B1 (fr) 2011-09-27 2013-10-04 Sederma Sa Nouvelle utilisation cosmetique d'un extrait d'albizia julibrissin et composition topique correspondante
EP2623094A1 (fr) * 2012-02-02 2013-08-07 DSM IP Assets B.V. Utilisation d'extrait d'edelweiss
FR2998570B1 (fr) 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
FR3021319B1 (fr) 2014-05-22 2018-08-31 Sederma Peptides, compositions les comprenant et utilisations notamment cosmetiques
KR101740097B1 (ko) * 2014-10-13 2017-05-29 주식회사 바이오에프디엔씨 에델바이스 식물 세포 배양 추출물을 함유한 항염 및 항노화 효과를 지닌 피부 외용제 조성물 및 그 제조방법
FR3029782B1 (fr) 2014-12-16 2019-06-07 Sederma Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques
FR3031454B1 (fr) * 2015-01-13 2018-05-11 Sederma Utilisation de cellules vegetales de leontopodium alpinum pour un traitement cosmetique et ingredient actif cosmetique correspondant
FR3052453B1 (fr) 2016-06-14 2018-05-18 Sederma Peptide, composition le comprenant et utilisations notamment cosmetiques

Also Published As

Publication number Publication date
CN114502140A (zh) 2022-05-13
FR3101542A1 (fr) 2021-04-09
WO2021064173A1 (fr) 2021-04-08
EP4037656A1 (fr) 2022-08-10

Similar Documents

Publication Publication Date Title
Gaur et al. Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging
Maan et al. Cell recruitment by amnion chorion grafts promotes neovascularization
Guo et al. Comparison of odontogenic differentiation of human dental follicle cells and human dental papilla cells
Clark et al. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome
Taub et al. Stem cells in dermatology and anti-aging care of the skin
JP2009514546A (ja) 多孔性及び引っ張り強度を改善させたコラーゲン性皮膚代用物及び機械的な刺激システムを利用したその培養方法
Ito et al. Low-intensity pulsed ultrasound inhibits messenger RNA expression of matrix metalloproteinase-13 induced by interleukin-1β in chondrocytes in an intensity-dependent manner
CN106967679B (zh) 一种高浓度葡萄糖溶液激活的间充质干细胞条件培养基的制备方法及其应用
Balzano et al. Lessons from human umbilical cord: Gender differences in stem cells from Wharton’s jelly
Pan et al. Conditioned medium derived from human amniotic stem cells delays H2O2‑induced premature senescence in human dermal fibroblasts
TR201913215A2 (tr) Deri̇ hücreleri̇ni̇n canliliğini ve saç çikartma kapasi̇teleri̇ni̇ arttirmasi i̇çi̇n bi̇tki̇sel eksozomlarin kullanimi
Madonna et al. Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells
Kim et al. Involvement of TLR3-dependent PGES expression in immunosuppression by human bone marrow mesenchymal stem cells
Putra et al. Topical gel of mesenchymal stem cells-conditioned medium under TNF-α precondition accelerates wound closure healing in full-thickness skin defect animal model
FR3101542B1 (fr) UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION
Movahednia et al. Potential applications of keratinocytes derived from human embryonic stem cells
KR20210084527A (ko) 줄기세포 재료 및 그 제조방법
KR20130009117A (ko) 줄기세포 배양액의 유효성분을 이용한 발모 촉진용 조성물
WO2020185056A3 (fr) Procédé de culture de cellules immunitaires allogéniques, culture de cellules immunitaires ainsi obtenues, et agent thérapeutique de cellules immunitaires les comprenant
Guo et al. Effects of mechanical stimulus on mesenchymal stem cells differentiation toward cardiomyocytes
CN113980896B (zh) Irf1在调控间充质干细胞免疫调节作用及产品上的应用
AU2019356414A8 (en) Binding proteins specific for HA-1H and uses thereof
Fridman et al. Comparison of the effects of KE and AED peptides on functional activity of human skin fibroblasts during their replicative aging
JP2017529066A5 (fr)
Chistiakova et al. Influence of human fetal mesenchymal stem cells on glioma cell proliferation. A consequence of cellular crosstalk

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210409

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6